Anti-embolic and anti-oxidative effects of a novel (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against isoproterenol and vitamin-K induced ischemic stroke
This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male Wistar rats. Animals were randomly allocated in...
Saved in:
| Published in: | Archives of physiology and biochemistry Vol. 127; no. 6; pp. 527 - 540 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Taylor & Francis
02.11.2021
|
| Subjects: | |
| ISSN: | 1381-3455, 1744-4160, 1744-4160 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male Wistar rats. Animals were randomly allocated into four groups: control, Stroke, Stroke + Ace (acenocoumarol) and Stroke + HC-treated group for 7 days. Our results showed that stroke group evidenced atrial flutter, significant cardiac hypertrophy (+23%) and increase in plasma level of troponin-T, with disturbance in plasma ionic levels and rise in fibrinogen rate and oxidative damages in heart and brain. Moreover, the histological findings revealed myocardium necrosis, cardiac cavity thrombi and brain injury as compared to normal rats. However, HC-treatment significantly prevents the embolic process, improves cerebral damages and mitigates the oxidative stress markers in stroke rats. Overall, HC is endowed with a thrombolytic potential against MI and stroke in such severe conditions through an anti-vit K (AVK) mechanism. |
|---|---|
| AbstractList | This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male
rats. Animals were randomly allocated into four groups: control, Stroke, Stroke + Ace (acenocoumarol) and Stroke + HC-treated group for 7 days. Our results showed that stroke group evidenced atrial flutter, significant cardiac hypertrophy (+23%) and increase in plasma level of troponin-T, with disturbance in plasma ionic levels and rise in fibrinogen rate and oxidative damages in heart and brain. Moreover, the histological findings revealed myocardium necrosis, cardiac cavity thrombi and brain injury as compared to normal rats. However, HC-treatment significantly prevents the embolic process, improves cerebral damages and mitigates the oxidative stress markers in stroke rats. Overall, HC is endowed with a thrombolytic potential against MI and stroke in such severe conditions through an anti-vit K (AVK) mechanism. This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male Wistar rats. Animals were randomly allocated into four groups: control, Stroke, Stroke + Ace (acenocoumarol) and Stroke + HC-treated group for 7 days. Our results showed that stroke group evidenced atrial flutter, significant cardiac hypertrophy (+23%) and increase in plasma level of troponin-T, with disturbance in plasma ionic levels and rise in fibrinogen rate and oxidative damages in heart and brain. Moreover, the histological findings revealed myocardium necrosis, cardiac cavity thrombi and brain injury as compared to normal rats. However, HC-treatment significantly prevents the embolic process, improves cerebral damages and mitigates the oxidative stress markers in stroke rats. Overall, HC is endowed with a thrombolytic potential against MI and stroke in such severe conditions through an anti-vit K (AVK) mechanism.This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male Wistar rats. Animals were randomly allocated into four groups: control, Stroke, Stroke + Ace (acenocoumarol) and Stroke + HC-treated group for 7 days. Our results showed that stroke group evidenced atrial flutter, significant cardiac hypertrophy (+23%) and increase in plasma level of troponin-T, with disturbance in plasma ionic levels and rise in fibrinogen rate and oxidative damages in heart and brain. Moreover, the histological findings revealed myocardium necrosis, cardiac cavity thrombi and brain injury as compared to normal rats. However, HC-treatment significantly prevents the embolic process, improves cerebral damages and mitigates the oxidative stress markers in stroke rats. Overall, HC is endowed with a thrombolytic potential against MI and stroke in such severe conditions through an anti-vit K (AVK) mechanism. This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male Wistar rats. Animals were randomly allocated into four groups: control, Stroke, Stroke + Ace (acenocoumarol) and Stroke + HC-treated group for 7 days. Our results showed that stroke group evidenced atrial flutter, significant cardiac hypertrophy (+23%) and increase in plasma level of troponin-T, with disturbance in plasma ionic levels and rise in fibrinogen rate and oxidative damages in heart and brain. Moreover, the histological findings revealed myocardium necrosis, cardiac cavity thrombi and brain injury as compared to normal rats. However, HC-treatment significantly prevents the embolic process, improves cerebral damages and mitigates the oxidative stress markers in stroke rats. Overall, HC is endowed with a thrombolytic potential against MI and stroke in such severe conditions through an anti-vit K (AVK) mechanism. |
| Author | Ncir, Marwa Elfeki, Abdelfattah Khdhiri, Emna Allouche, Noureddine Ghazouani, Lakhdar Ammar, Houcine Abid, Souhir Hajji, Raouf Mnafgui, Kais Zaafouri, Zouhaier |
| Author_xml | – sequence: 1 givenname: Kais surname: Mnafgui fullname: Mnafgui, Kais organization: Laboratory of Animal Physiology, Faculty of Sciences of Sfax, University of Sfax – sequence: 2 givenname: Emna surname: Khdhiri fullname: Khdhiri, Emna organization: Laboratory of Applied Chemistry HCGP, Faculty of Science, University of Sfax – sequence: 3 givenname: Lakhdar surname: Ghazouani fullname: Ghazouani, Lakhdar organization: Research Unit of Macromolecular Biochemistry and Genetics, Faculty of Sciences of Gafsa – sequence: 4 givenname: Marwa surname: Ncir fullname: Ncir, Marwa organization: Laboratory of Animal Physiology, Faculty of Sciences of Sfax, University of Sfax – sequence: 5 givenname: Zouhaier surname: Zaafouri fullname: Zaafouri, Zouhaier organization: Department of Surgery, Hospital of Sidi Bouzid – sequence: 6 givenname: Noureddine surname: Allouche fullname: Allouche, Noureddine organization: Laboratory of Organic Chemistry LR17ES08 (Natural Substances Team), Faculty of Sciences of Sfax, University of Sfax – sequence: 7 givenname: Abdelfattah surname: Elfeki fullname: Elfeki, Abdelfattah organization: Laboratory of Animal Physiology, Faculty of Sciences of Sfax, University of Sfax – sequence: 8 givenname: Houcine surname: Ammar fullname: Ammar, Houcine organization: Laboratory of Applied Chemistry HCGP, Faculty of Science, University of Sfax – sequence: 9 givenname: Souhir surname: Abid fullname: Abid, Souhir organization: Chemistry Department, College of Science and Arts, Jouf University – sequence: 10 givenname: Raouf surname: Hajji fullname: Hajji, Raouf organization: Faculty of Medicine of Sousse, Department of Internal Medicine, Hospital of Sidi Bouzid |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31469295$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkc1yFCEUhbusWOZHH0GL5cyCEbpppik3plIxsUzpRtcUDbcdlIYIzJjOymfyBfIuPomMM7NxoQsK6vKdew-c0-rIBw9V9ZySBSUdeUmbjjasbRc1oWJBebsUhDyqTuiSMcwoJ0flXBi8hY6r05S-EELrTtAn1XFDGRe1aE-qh3OfLYaxD85qpLwpqxTCnTUq2w0gGAbQOaEwIIV82IBDs8s5ZliN1gf8_tePn3hG8WyJV5OJ4W7CdVEHXF9jvYphBI8bPLk5gryanDXgYY568Pdhy6v7UkHqs7I-ZWRTuI0hQwQf3B8zG5u3c_A7ZL1ZazCF0SsYi9eUY_gKT6vHg3IJnu33s-rTm8uPF9f45sPV24vzG6wbzjMeOBXl1wQIPjA9CNq0PekNmNY0BHRfsx5Y13QdZ7UeTFuu-JL2IJToNOemOatmu77F4Lc1pCzH4gScUx7COsm67hpKGaWkoC_26LofwcjbaEcVJ3n49AK82gE6hpQiDFKXZ2YbfI7KOkmJ3EYsDxHLbcRyH3FRt3-pDwP-p3u901k_hDiq7yE6I7OaXIhDVF7bVCz-s8Vv3eq_YQ |
| CitedBy_id | crossref_primary_10_1155_2020_2432918 crossref_primary_10_1007_s42250_024_01011_3 crossref_primary_10_1080_00397911_2022_2095213 crossref_primary_10_1007_s11064_021_03351_9 crossref_primary_10_1002_jbt_22747 crossref_primary_10_1016_j_sajb_2025_07_006 |
| Cites_doi | 10.1111/j.1365-2125.1992.tb05634.x 10.1159/000352050 10.1007/s11239-005-2473-4 10.1046/j.1538-7836.2003.00052.x 10.1001/archinte.160.21.3196 10.1161/CIRCULATIONAHA.110.986661 10.1016/j.amjcard.2013.02.067 10.1097/WCO.0b013e32813ba151 10.1038/jcbfm.2013.203 10.1016/S0021-9258(19)52451-6 10.1161/STROKEAHA.108.533505 10.1111/j.1538-7836.2011.04361.x 10.1136/bmj.320.7248.1502 10.1016/S0072-9752(08)01903-9 10.1016/j.biopha.2017.11.093 10.1096/fj.02-1086fje 10.3390/nu10111575 10.1007/s12975-013-0308-8 10.1016/j.ccl.2015.12.003 10.1212/01.WNL.0000063309.41867.0F 10.1007/s12012-015-9343-x 10.1126/science.179.4073.588 10.1001/jama.285.22.2864 10.1038/sj.bjp.0707594 10.1152/physrev.1999.79.4.1431 10.1007/112_2018_13 10.1159/000226773 10.1016/j.freeradbiomed.2005.06.025 10.1016/S0024-3205(99)00455-5 10.1358/dot.2008.44.10.1265487 10.1016/S0021-9150(97)00087-7 10.1007/978-3-319-49674-0_13 10.1016/j.jep.2016.04.060 10.1016/S0074-7742(07)82016-2 10.1016/j.jstrokecerebrovasdis.2017.09.011 10.1016/j.cjca.2018.02.016 10.1038/nrneurol.2012.33 10.1007/s13311-011-0053-1 10.1016/j.clineuro.2017.05.019 10.2174/092986710790936284 10.1179/174329210X12650506623168 10.2147/TCRM.S84210 10.1016/j.jns.2006.01.020 10.5114/fn.2012.30522 10.1161/01.STR.32.1.133 10.4103/1673-5374.150724 10.1016/j.arr.2013.09.004 10.1161/ATVBAHA.117.308564 10.1016/j.cjca.2018.01.001 10.1055/s-2001-18870 10.1155/2013/963248 10.1016/j.clinthera.2017.05.358 10.2165/00003088-200544120-00003 10.1016/0891-5849(88)90023-8 |
| ContentType | Journal Article |
| Copyright | 2019 Informa UK Limited, trading as Taylor & Francis Group 2019 |
| Copyright_xml | – notice: 2019 Informa UK Limited, trading as Taylor & Francis Group 2019 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1080/13813455.2019.1657900 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry |
| EISSN | 1744-4160 |
| EndPage | 540 |
| ExternalDocumentID | 31469295 10_1080_13813455_2019_1657900 1657900 |
| Genre | Research Article Randomized Controlled Trial, Veterinary Journal Article |
| GroupedDBID | --- 00X 03L 0R~ 23N 36B 4.4 53G 5GY 6J9 AAGDL AALUX AAMIU AAPUL AAQRR ABBKH ABDBF ABEIZ ABJNI ABLIJ ABLKL ABUPF ABWVI ABXYU ACENM ACGEJ ACGFO ACGFS ACIEZ ACUHS ADCVX ADRBQ ADXPE AECIN AENEX AEOZL AFKVX AFRVT AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE AQTUD BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO EAP EAS EBB EBC EBD EBS EBX EHN EMB EMK EMOBN EPL EPT EST ESX F5P H13 HZ~ KRBQP KSSTO KWAYT KYCEM LJTGL M4Z O9- Q~Q RNANH RVRKI SV3 TASJS TBQAZ TDBHL TERGH TFDNU TFL TFW TUROJ TUS UEQFS V1S ~1N AAYXX CITATION .GJ 5VS AALIY AAORF AAPXX ABWCV ABZEW ACKZS ACOPL ACYZI ADFOM ADFZZ ADYSH AEIIZ AFLEI AJVHN AWYRJ BRMBE CAG CGR COF CUY CVF CYYVM CZDIS DRXRE DWTOO ECM EIF EJD JENTW M44 NPM NUSFT QQXMO ZXP 7X8 |
| ID | FETCH-LOGICAL-c366t-f6190809e96f4cf9135b0bded5d30ecb24be48388642cfd5bde671be9a98c66d3 |
| IEDL.DBID | TFW |
| ISICitedReferencesCount | 9 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000484264400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1381-3455 1744-4160 |
| IngestDate | Thu Sep 04 17:30:33 EDT 2025 Mon Jul 21 05:56:07 EDT 2025 Tue Nov 18 21:46:44 EST 2025 Sat Nov 29 01:43:44 EST 2025 Mon Oct 20 23:47:21 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Stroke fibrinogen atrial flutter coumarin myocardial infarction |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c366t-f6190809e96f4cf9135b0bded5d30ecb24be48388642cfd5bde671be9a98c66d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 31469295 |
| PQID | 2283114110 |
| PQPubID | 23479 |
| PageCount | 14 |
| ParticipantIDs | crossref_citationtrail_10_1080_13813455_2019_1657900 proquest_miscellaneous_2283114110 crossref_primary_10_1080_13813455_2019_1657900 informaworld_taylorfrancis_310_1080_13813455_2019_1657900 pubmed_primary_31469295 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-11-02 |
| PublicationDateYYYYMMDD | 2021-11-02 |
| PublicationDate_xml | – month: 11 year: 2021 text: 2021-11-02 day: 02 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Archives of physiology and biochemistry |
| PublicationTitleAlternate | Arch Physiol Biochem |
| PublicationYear | 2021 |
| Publisher | Taylor & Francis |
| Publisher_xml | – name: Taylor & Francis |
| References | Hatano S. (CIT0015) 1976; 54 CIT0030 CIT0032 CIT0031 CIT0034 CIT0033 Mishra L.D. (CIT0038) 2002; 46 CIT0036 CIT0037 CIT0039 CIT0041 CIT0040 CIT0043 CIT0042 CIT0045 CIT0044 CIT0003 CIT0047 CIT0002 CIT0046 Ábrahám H. (CIT0001) 2002; 142 CIT0005 CIT0049 CIT0004 CIT0048 CIT0007 CIT0006 CIT0009 CIT0008 CIT0050 CIT0051 CIT0010 CIT0054 CIT0053 CIT0012 CIT0056 CIT0011 CIT0055 Trailokya A. (CIT0052) 2016; 64 CIT0014 CIT0058 CIT0013 CIT0057 CIT0016 CIT0059 CIT0018 CIT0017 CIT0019 CIT0060 CIT0021 CIT0020 CIT0023 CIT0022 Mărgăritescu O.A. (CIT0035) 2009; 50 CIT0024 Kakkar P. (CIT0025) 1984; 21 CIT0027 CIT0026 CIT0029 CIT0028 |
| References_xml | – ident: CIT0037 doi: 10.1111/j.1365-2125.1992.tb05634.x – ident: CIT0003 doi: 10.1159/000352050 – ident: CIT0005 doi: 10.1007/s11239-005-2473-4 – ident: CIT0016 doi: 10.1046/j.1538-7836.2003.00052.x – ident: CIT0010 doi: 10.1001/archinte.160.21.3196 – ident: CIT0021 doi: 10.1161/CIRCULATIONAHA.110.986661 – ident: CIT0029 doi: 10.1016/j.amjcard.2013.02.067 – ident: CIT0040 doi: 10.1097/WCO.0b013e32813ba151 – volume: 46 start-page: 87 year: 2002 ident: CIT0038 publication-title: Indian journal of anaesthesia – ident: CIT0023 doi: 10.1038/jcbfm.2013.203 – ident: CIT0034 doi: 10.1016/S0021-9258(19)52451-6 – volume: 50 start-page: 327 issue: 3 year: 2009 ident: CIT0035 publication-title: Romanian journal of morphology and embryology – volume: 54 start-page: 541 issue: 5 year: 1976 ident: CIT0015 publication-title: Bulletin of world health organisation – ident: CIT0059 doi: 10.1161/STROKEAHA.108.533505 – ident: CIT0041 doi: 10.1111/j.1538-7836.2011.04361.x – ident: CIT0022 doi: 10.1136/bmj.320.7248.1502 – ident: CIT0008 doi: 10.1016/S0072-9752(08)01903-9 – ident: CIT0049 doi: 10.1016/j.biopha.2017.11.093 – ident: CIT0020 doi: 10.1096/fj.02-1086fje – ident: CIT0031 doi: 10.3390/nu10111575 – ident: CIT0044 doi: 10.1007/s12975-013-0308-8 – ident: CIT0018 doi: 10.1016/j.ccl.2015.12.003 – ident: CIT0024 doi: 10.1212/01.WNL.0000063309.41867.0F – ident: CIT0039 doi: 10.1007/s12012-015-9343-x – ident: CIT0051 doi: 10.1126/science.179.4073.588 – ident: CIT0012 doi: 10.1001/jama.285.22.2864 – ident: CIT0013 doi: 10.1038/sj.bjp.0707594 – ident: CIT0032 doi: 10.1152/physrev.1999.79.4.1431 – ident: CIT0033 doi: 10.1007/112_2018_13 – ident: CIT0027 doi: 10.1159/000226773 – volume: 21 start-page: 130 issue: 2 year: 1984 ident: CIT0025 publication-title: Indian journal of biochemistry and biophysics – ident: CIT0006 doi: 10.1016/j.freeradbiomed.2005.06.025 – ident: CIT0042 doi: 10.1016/S0024-3205(99)00455-5 – ident: CIT0030 doi: 10.1358/dot.2008.44.10.1265487 – ident: CIT0050 doi: 10.1016/S0021-9150(97)00087-7 – ident: CIT0058 doi: 10.1007/978-3-319-49674-0_13 – ident: CIT0028 doi: 10.1016/j.jep.2016.04.060 – ident: CIT0047 doi: 10.1016/S0074-7742(07)82016-2 – ident: CIT0019 doi: 10.1016/j.jstrokecerebrovasdis.2017.09.011 – ident: CIT0060 doi: 10.1016/j.cjca.2018.02.016 – ident: CIT0057 doi: 10.1038/nrneurol.2012.33 – volume: 142 start-page: 131 issue: 9 year: 2002 ident: CIT0001 publication-title: Experimental brain research – ident: CIT0043 doi: 10.1007/s13311-011-0053-1 – ident: CIT0046 doi: 10.1016/j.clineuro.2017.05.019 – ident: CIT0048 doi: 10.2174/092986710790936284 – ident: CIT0055 doi: 10.1179/174329210X12650506623168 – ident: CIT0036 doi: 10.2147/TCRM.S84210 – ident: CIT0053 doi: 10.1016/j.jns.2006.01.020 – ident: CIT0045 doi: 10.5114/fn.2012.30522 – ident: CIT0007 doi: 10.1161/01.STR.32.1.133 – ident: CIT0004 doi: 10.4103/1673-5374.150724 – ident: CIT0009 doi: 10.1016/j.arr.2013.09.004 – ident: CIT0026 doi: 10.1161/ATVBAHA.117.308564 – ident: CIT0014 doi: 10.1016/j.cjca.2018.01.001 – ident: CIT0017 doi: 10.1055/s-2001-18870 – ident: CIT0056 doi: 10.1155/2013/963248 – ident: CIT0002 doi: 10.1016/j.clinthera.2017.05.358 – volume: 64 start-page: 88 issue: 2 year: 2016 ident: CIT0052 publication-title: Journal of the association of physicians of India – ident: CIT0054 doi: 10.2165/00003088-200544120-00003 – ident: CIT0011 doi: 10.1016/0891-5849(88)90023-8 |
| SSID | ssj0012891 |
| Score | 2.3159997 |
| Snippet | This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene)... This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene)... |
| SourceID | proquest pubmed crossref informaworld |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 527 |
| SubjectTerms | Animals atrial flutter Brain Ischemia - drug therapy Brain Ischemia - metabolism coumarin fibrinogen Ischemic Stroke Isoproterenol Male myocardial infarction Myocardium - metabolism Oxidative Stress Rats Rats, Wistar Stroke Stroke - drug therapy Stroke - metabolism Vitamin K - metabolism Vitamins |
| Title | Anti-embolic and anti-oxidative effects of a novel (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against isoproterenol and vitamin-K induced ischemic stroke |
| URI | https://www.tandfonline.com/doi/abs/10.1080/13813455.2019.1657900 https://www.ncbi.nlm.nih.gov/pubmed/31469295 https://www.proquest.com/docview/2283114110 |
| Volume | 127 |
| WOSCitedRecordID | wos000484264400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAWR databaseName: Taylor & Francis Online Journals customDbUrl: eissn: 1744-4160 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012891 issn: 1381-3455 databaseCode: TFW dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagQoILj5bH8qiMhNDuwWUTOw8fV1VXlZBWHIrYW-RXaNSsjTbpiu2J38Qf4L_wSxg7yYoeqh7gkIvjsZ3MOP7GnnyD0DuWCR3nqSSJylLCmGJEqEiRVE0BPjMJTocKySayxSJfLvmnPpqw6cMqvQ9ddkQR4VvtJ7eQzRAR9yGCVYayJPGBWfwoSpOMT73XDsje2_jZ_MvuHCHucuZ5CeJFhn94bmrl2up0jbv0ZgQaVqL5o__wDI_Rwx6G4llnN0_QHWP30cHMggu-2uL3OASGhh33fXT_eEgKd4B-zWxbEbOSnk4YQ-9wQYH7XunAII77-BDsSiywdRtT4_HJhIBuVpV1ZPH7x08yjsg4I-db7UNoSAzSjsSnRJ176gRLKNnWE2zAgmqf8dRMsDT2yvn64gpKsPgqKkC1uGpcoJlYG-vqMJhN1fp-yEdcWQ1Gq6GOCpQIGMbvLsxT9Hl-cnZ8SvocEETRNG1JCQ4evC9ueFoyVfKIJnIqtdGJplOjZMykYTnNc_CjVKkTuJVmkTRc8FylqabP0J511rxAmE1NIoSJoxJgo8yp4GWWmEzrEtrMuBkhNui-UD1Bus_TURdRz6M6KK3wSit6pY3Q0U7sW8cQcpsA_9uwijZszZRdHpWC3iL7drDCAjTvD3eENe6yKTyNEfi2gOZG6HlnnrvhUFgOAQYnL_-h51foQezDefyOevwa7bXrS_MG3VObtmrWh-hutswPw9z7AwIAKhI |
| linkProvider | Taylor & Francis |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQQSoXHi2P5WkkhHYPLnnYSXxcVV0tatnTInqLHNtpI7I22k1XbE_8Jv4A_4VfwthJVu2h6gEOuTie2MmMMw-Pv0HoPU2FirKkIEymCaFUUiJkKEkiAzCfaQFOh_TFJtLZLDs95VfPwri0SudDly1QhP9Xu8XtgtF9StzHENRMTBlzmVn8IExYygNw2-8y0LUurW8--brdSYjaqnmOhDia_hTPTY-5pp-uoZfebIN6XTR5-D_e4hF60FmieNyKzmN0R5s9tD824IUvNvgD9rmhPui-h3YP-7pw--j32DQV0YvCIQpjGB4uaLA_KuVBxHGXIoJtiQU2dq1rPDwaEWDPojKWzP78_EWGIRmm5HyjXBYNiYDakmhK5LlDTzAkJpt6hDUIUe2KnuoRLrS5tK6_uIQWLM5EBYYtrlbWI00stbG1n8y6atw45BhXRoHcKugjPSoChvnbb_oJ-jI5mh9OSVcGgsg4SRpSgo8H34trnpRUljyMWREUSium4kDLIqKFplmcZeBKyVIxuJWkYaG54JlMEhU_RTvGGv0cYRpoJoSOwhIsxyKLBS9TplOlSnhmyvUA0Z75ueww0l2pjjoPOyjVnmm5Y1reMW2ADrZk31uQkNsI-FXJyhsfnSnbUip5fAvtu14Mc-C8298RRtuLVe6QjMC9BYNugJ618rmdTgwaESxh9uIfRn6Ldqfzzyf5yafZ8Ut0P3LZPS7AHr1CO83yQr9G9-S6qVbLN34J_gWlqy1L |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQQcCFR8tjeRoJod2DyyZxnPi4Kl0VFa16KKK3yPGDRmTtajddsT3xm_gD_Bd-CWMnWdFD1QMccnE8tpMZxzP2l28QekszoeKclSSVGSOUSkqEjCRhcgzuMy0h6JAh2UQ2m-UnJ_yoQxMuO1ilj6FNSxQRvtV-cp8p0yPi3kewyiQ0TT0wi-9GLM34GKL2m4EcC0z6ePplc5AQt0nzvAjxMv1PPFc1c2l5ukReerULGpai6f3_8BAP0L3OD8WT1nAeohvabqOdiYUYfL7G73BAhoYt9210Z6_PCreDfk1sUxE9Lz2fMIbe4YIC971SgUIcdwAR7AwW2LqVrvFwf0RAOfPKOjL7_eMnGUZkmJHTtfIYGhKDtCPxAZGnnjvBkoSs6xHWYEK1T3mqR7jU9sL5-uICSrD4Kipwa3G1dIFnYqGtq8NgVlXj-yGHuLIKrFZBHRk4ETCM333Tj9Dn6f7x3gHpkkAQmTDWEAMRHrwvrjkzVBoeJWk5LpVWqUrGWpYxLTXNkzyHQEoalcItlkWl5oLnkjGVPEZb1ln9FGE61qkQOo4M-I1lnghuslRnShloM-N6gGiv-0J2DOk-UUddRB2Raq-0wiut6JQ2QLsbsbOWIuQ6Af63YRVN2JsxbSKVIrlG9k1vhQVo3p_uCKvd-bLwPEYQ3II7N0BPWvPcDCeB9RD84PTZP_T8Gt0--jAtPn2cHT5Hd2MP7fG76_ELtNUszvVLdEuummq5eBUm4B_Akyvv |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-embolic+and+anti-oxidative+effects+of+a+novel+%28E%29-4-amino-N%E2%80%B2-%281-%287-hydroxy-2-oxo-2H-chromen-3-yl%29+ethylidene%29+benzohydrazide+against+isoproterenol+and+vitamin-K+induced+ischemic+stroke&rft.jtitle=Archives+of+physiology+and+biochemistry&rft.au=Mnafgui%2C+Kais&rft.au=Khdhiri%2C+Emna&rft.au=Ghazouani%2C+Lakhdar&rft.au=Ncir%2C+Marwa&rft.date=2021-11-02&rft.issn=1381-3455&rft.eissn=1744-4160&rft.volume=127&rft.issue=6&rft.spage=527&rft.epage=540&rft_id=info:doi/10.1080%2F13813455.2019.1657900&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_13813455_2019_1657900 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1381-3455&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1381-3455&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1381-3455&client=summon |